COLLEGIUM PHARMACEUTICAL, INC cotiza a 21.53 USD y tiene una capitalización bursátil de $701M. En los últimos 12 meses ha facturado $808M con un margen de flujo de caja libre del 42.0%. Cotiza a 2.1 veces su flujo de caja libre (P/FCF) y a un PER de 14.6. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention def…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.92 | $1.76 | $2.04 |
| Estimado | $1.79 | $1.77 | $1.52 | $2.14 |
| Sorpresa | — | +8.5% | +15.8% | -4.7% |
| Métrica | COLL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 59.4% | 57.0% | +2.3% |
| Operating Margin | 23.0% | -38.6% | +61.6% |
| Net Margin | 8.1% | -33.6% | +41.6% |
| FCF Margin | 42.0% | -13.9% | +55.8% |
| ROE | 20.8% | -40.4% | +61.2% |
| ROA | 3.8% | -32.0% | +35.8% |
| Current Ratio | 1.57 | 2.84 | -1.27 |
| Debt / Equity | — | 0.28 | — |